IOVANCE BIOTHERAPEUTICS, INC. — Director's Dealing 2021

Jul 1, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
CIK: 0001425205
Period of Report: 2021-06-29

Reporting Person: Dukes Iain D. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-29	Stock Option (right to buy)	$26.33	A	70000	Acquired	2031-06-29	Common Stock (70000)	Direct

Footnotes

F1: These options are exercisable in four equal quarterly installments of 17,500 each following the date of grant, such that the options will be fully vested and exercisable on June 29, 2022.